RecruitingNCT04653428
German Registry for Transcatheter Tricuspid Valve Interventions
Sponsor
LMU Klinikum
Enrollment
600 participants
Start Date
Oct 1, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
Multicentre observational study of patients with severe tricuspid regurgitation and interventional treatment.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Interventional treatment of severe tricuspid regurgitation (isolated or in combination with another interventional treatment) with a CE certified product for tricuspid valve repair
- Informed consent corresponding to criteria of Good Clinical Practice and the decleration of Helsinki as well as to standards of the local ethic commission.
Exclusion Criteria2
- No agreement to participation
- Age < 18 years
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEInterventional treatment of tricuspid regurgitation
Interventional treatment for tricuspid regurgitatin with CE-certified products, e.g. edge-to-edge repair
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04653428
Related Trials
NHLBI and Cook Trans-Atrial Intra-Pericardial Tricuspid Annuloplasty (TRAIPTA) Early Feasibility Study
NCT064798242 locations
TriClip Japan Post-Approval Study
NCT075096581 location
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
NCT0409714579 locations
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
NCT0584828411 locations
Berlin Registry of Right Heart Interventions
NCT045701631 location